Type |
Details |
Score |
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1998
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1716
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
2062
 |
Fragment?: |
false |
|
•
•
•
•
•
|
DO Term |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 |
Background: |
Not Specified |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1081
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
1100
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamada M |
Year: |
2001 |
Journal: |
Mol Cell Biol |
Title: |
Loss of hippocampal CA3 pyramidal neurons in mice lacking STAM1. |
Volume: |
21 |
Issue: |
11 |
Pages: |
3807-19 |
|
•
•
•
•
•
|
Allele |
Name: |
Janus kinase 3; mutation 4, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, chemically induced mutation, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
Janus kinase 3; mutation 5, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
chemically induced mutation, mutant strain, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
Janus kinase 3; mutation 6, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, chemically induced mutation, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
Janus kinase 3; mutation 7, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
chemically induced mutation, mutant strain, coisogenic |
|
•
•
•
•
•
|
Allele |
Name: |
Janus kinase 3; mutation 8, Bruce Beutler |
Allele Type: |
Chemically induced (ENU) |
Attribute String: |
Not Specified |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 |
Background: |
C57BL/6J-Jak3 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 |
Background: |
C57BL/6J-Jak3 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 |
Background: |
C57BL/6J-Jak3 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 |
Background: |
C57BL/6J-Jak3 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Sharma PS |
Year: |
2009 |
Journal: |
Curr Pharm Des |
Title: |
Receptor tyrosine kinase inhibitors as potent weapons in war against cancers. |
Volume: |
15 |
Issue: |
7 |
Pages: |
758-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li E |
Year: |
2006 |
Journal: |
Biochemistry |
Title: |
Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. |
Volume: |
45 |
Issue: |
20 |
Pages: |
6241-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Roskoski R Jr |
Year: |
2005 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Src kinase regulation by phosphorylation and dephosphorylation. |
Volume: |
331 |
Issue: |
1 |
Pages: |
1-14 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, chemically induced mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 Trdc/Trdc |
Background: |
involves: C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 Tg(Lck-Jak3)2Ljb/? |
Background: |
involves: 129S4/SvJae * C3H * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 Tg(Lck-Jak3)1Ljb/? |
Background: |
involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 Tg(Lck-Jak3)2Ljb/? |
Background: |
involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Jak3/Jak3 |
Background: |
C57BL/6J-Jak3 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamada M |
Year: |
2002 |
Journal: |
Mol Cell Biol |
Title: |
Signal-transducing adaptor molecules STAM1 and STAM2 are required for T-cell development and survival. |
Volume: |
22 |
Issue: |
24 |
Pages: |
8648-58 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lim J |
Year: |
2011 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Solution structure of UIM and interaction of tandem ubiquitin binding domains in STAM1 with ubiquitin. |
Volume: |
405 |
Issue: |
1 |
Pages: |
24-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kapuralin K |
Year: |
2015 |
Journal: |
Mol Cell Neurosci |
Title: |
STAM2, a member of the endosome-associated complex ESCRT-0 is highly expressed in neurons. |
Volume: |
67 |
|
Pages: |
104-15 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SH3 domain of STAM1 (signal transducing adapter molecule 1). STAM1 is part of the endosomal sorting complex required for transport (ESCRT-0) and is involved in sorting ubiquitinated cargo proteins from the endosome []. It may also be involved in the regulation of IL2 and GM-CSF mediated signaling, and has been implicated in neural cell survival [, ]. STAMs were discovered as proteins that are highly phosphorylated following cytokine and growth factor stimulation []. They function in cytokine signaling and surface receptor degradation, as well as regulate Golgi morphology. They associate with many proteins including Jak2 and Jak3 tyrosine kinases [], Hrs, AMSH, and UBPY. STAM adaptor proteins contain VHS (Vps27, Hrs, STAM homology), ubiquitin interacting (UIM), and SH3 domains []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the SH3 domain of STAM2 (signal transducing adapter molecule 2). STAM2, a subunit of the ESCRT-0 complex, is an endosomal protein acting as a regulator of receptor signaling and trafficking. It contains an N-terminal VHS domain (Vps-27/Hrs/Stam), UIM (ubiquitin-interacting motif), SH3 (Src homology 3), CC ("coiled coil"), SSM (STAM-specific motif) and C-terminal ITAM (immunoreceptor tyrosine-based activation motif) domain. It may play a regulatory role in the endosomal sorting of ubiquitinated membrane proteins []. STAMs were discovered as proteins that are highly phosphorylated following cytokine and growth factor stimulation []. They function in cytokine signaling and surface receptor degradation, as well as regulate Golgi morphology. They associate with many proteins including Jak2 and Jak3 tyrosine kinases [], Hrs, AMSH, and UBPY. STAM adaptor proteins contain VHS (Vps27, Hrs, STAM homology), ubiquitin interacting (UIM), and SH3 domains []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Asao H |
Year: |
1997 |
Journal: |
J Biol Chem |
Title: |
Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. |
Volume: |
272 |
Issue: |
52 |
Pages: |
32785-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lohi O |
Year: |
2001 |
Journal: |
FEBS Lett |
Title: |
STAM/EAST/Hbp adapter proteins--integrators of signalling pathways. |
Volume: |
508 |
Issue: |
3 |
Pages: |
287-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Endo K |
Year: |
2000 |
Journal: |
FEBS Lett |
Title: |
STAM2, a new member of the STAM family, binding to the Janus kinases. |
Volume: |
477 |
Issue: |
1-2 |
Pages: |
55-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hanks SK |
Year: |
1988 |
Journal: |
Science |
Title: |
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. |
Volume: |
241 |
Issue: |
4861 |
Pages: |
42-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Manning G |
Year: |
2002 |
Journal: |
Trends Biochem Sci |
Title: |
Evolution of protein kinase signaling from yeast to man. |
Volume: |
27 |
Issue: |
10 |
Pages: |
514-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Manning G |
Year: |
2002 |
Journal: |
Science |
Title: |
The protein kinase complement of the human genome. |
Volume: |
298 |
Issue: |
5600 |
Pages: |
1912-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stout TJ |
Year: |
2004 |
Journal: |
Curr Pharm Des |
Title: |
High-throughput structural biology in drug discovery: protein kinases. |
Volume: |
10 |
Issue: |
10 |
Pages: |
1069-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li B |
Year: |
2004 |
Journal: |
Comb Chem High Throughput Screen |
Title: |
Creating chemical diversity to target protein kinases. |
Volume: |
7 |
Issue: |
5 |
Pages: |
453-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Endo TA |
Year: |
1997 |
Journal: |
Nature |
Title: |
A new protein containing an SH2 domain that inhibits JAK kinases. |
Volume: |
387 |
Issue: |
6636 |
Pages: |
921-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yi Z |
Year: |
2014 |
Journal: |
Nat Immunol |
Title: |
The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2. |
Volume: |
15 |
Issue: |
9 |
Pages: |
866-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Patra AK |
Year: |
2013 |
Journal: |
Nat Immunol |
Title: |
An alternative NFAT-activation pathway mediated by IL-7 is critical for early thymocyte development. |
Volume: |
14 |
Issue: |
2 |
Pages: |
127-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hellgren G |
Year: |
1999 |
Journal: |
Growth Horm IGF Res |
Title: |
The growth hormone receptor associates with Jak1, Jak2 and Tyk2 in human liver. |
Volume: |
9 |
Issue: |
3 |
Pages: |
212-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Grunewald SM |
Year: |
1997 |
Journal: |
J Biol Chem |
Title: |
A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation, and signal transduction. |
Volume: |
272 |
Issue: |
3 |
Pages: |
1480-3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Y |
Year: |
2005 |
Journal: |
J Immunol |
Title: |
IL-15 activates telomerase and minimizes telomere loss and may preserve the replicative life span of memory CD8+ T cells in vitro. |
Volume: |
174 |
Issue: |
7 |
Pages: |
4019-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rollings CM |
Year: |
2018 |
Journal: |
Sci Signal |
Title: |
Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs. |
Volume: |
11 |
Issue: |
526 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Lim M |
Year: |
2020 |
Journal: |
Mol Cell Biol |
Title: |
Janus Kinase Mutations in Mice Lacking PU.1 and Spi-B Drive B Cell Leukemia through Reactive Oxygen Species-Induced DNA Damage. |
Volume: |
40 |
Issue: |
18 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Simoncic PD |
Year: |
2002 |
Journal: |
Curr Biol |
Title: |
The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. |
Volume: |
12 |
Issue: |
6 |
Pages: |
446-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang Z |
Year: |
2005 |
Journal: |
J Immunol |
Title: |
IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor. |
Volume: |
174 |
Issue: |
3 |
Pages: |
1332-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sa Q |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
IL-2 produced by CD8+ immune T cells can augment their IFN-γ production independently from their proliferation in the secondary response to an intracellular pathogen. |
Volume: |
190 |
Issue: |
5 |
Pages: |
2199-207 |
|
•
•
•
•
•
|
Publication |
First Author: |
van der Weyden L |
Year: |
2015 |
Journal: |
BMC Cancer |
Title: |
Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/-) leukemia. |
Volume: |
15 |
|
Pages: |
585 |
|
•
•
•
•
•
|
Publication |
First Author: |
MartÃn-Lorenzo A |
Year: |
2015 |
Journal: |
Cancer Discov |
Title: |
Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility. |
Volume: |
5 |
Issue: |
12 |
Pages: |
1328-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou B |
Year: |
2023 |
Journal: |
Eur J Immunol |
Title: |
Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression. |
Volume: |
53 |
Issue: |
10 |
Pages: |
e2250226 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hoffmeyer A |
Year: |
2001 |
Journal: |
Mol Cell Biol |
Title: |
Gadd45gamma is dispensable for normal mouse development and T-cell proliferation. |
Volume: |
21 |
Issue: |
9 |
Pages: |
3137-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsujino S |
Year: |
2000 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Differential requirement of the cytoplasmic subregions of gamma c chain in T cell development and function. |
Volume: |
97 |
Issue: |
19 |
Pages: |
10514-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tsujino S |
Year: |
1999 |
Journal: |
Genes Cells |
Title: |
Critical role of the membrane-proximal, proline-rich motif of the interleukin-2 receptor gammac chain in the Jak3-independent signal transduction. |
Volume: |
4 |
Issue: |
6 |
Pages: |
363-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen Y |
Year: |
2016 |
Journal: |
Oncogene |
Title: |
Identification of an orally available compound with potent and broad FLT3 inhibition activity. |
Volume: |
35 |
Issue: |
23 |
Pages: |
2971-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ding Y |
Year: |
2019 |
Journal: |
J Immunol |
Title: |
CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells. |
Volume: |
203 |
Issue: |
1 |
Pages: |
93-104 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jamrog L |
Year: |
2018 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice. |
Volume: |
115 |
Issue: |
41 |
Pages: |
10357-10362 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsumoto M |
Year: |
1999 |
Journal: |
J Immunol |
Title: |
IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. |
Volume: |
162 |
Issue: |
2 |
Pages: |
1056-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin JX |
Year: |
1996 |
Journal: |
J Biol Chem |
Title: |
Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. |
Volume: |
271 |
Issue: |
18 |
Pages: |
10738-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Uckun FM |
Year: |
2007 |
Journal: |
Arzneimittelforschung |
Title: |
Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis. |
Volume: |
57 |
Issue: |
6 |
Pages: |
320-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Montresor A |
Year: |
2013 |
Journal: |
J Cell Biol |
Title: |
JAK tyrosine kinases promote hierarchical activation of Rho and Rap modules of integrin activation. |
Volume: |
203 |
Issue: |
6 |
Pages: |
1003-19 |
|
•
•
•
•
•
|
Publication |
First Author: |
Inoue M |
Year: |
2018 |
Journal: |
Nat Immunol |
Title: |
Arginine methylation controls the strength of γc-family cytokine signaling in T cell maintenance. |
Volume: |
19 |
Issue: |
11 |
Pages: |
1265-1276 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee-Sundlov MM |
Year: |
2021 |
Journal: |
Blood |
Title: |
Immune cells surveil aberrantly sialylated O-glycans on megakaryocytes to regulate platelet count. |
Volume: |
138 |
Issue: |
23 |
Pages: |
2408-2424 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tachibana H |
Year: |
2022 |
Journal: |
Carcinogenesis |
Title: |
Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans. |
Volume: |
43 |
Issue: |
7 |
Pages: |
693-703 |
|
•
•
•
•
•
|
Publication |
First Author: |
Witalisz-Siepracka A |
Year: |
2018 |
Journal: |
Front Immunol |
Title: |
Loss of JAK1 Drives Innate Immune Deficiency. |
Volume: |
9 |
|
Pages: |
3108 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamashita M |
Year: |
2000 |
Journal: |
J Exp Med |
Title: |
T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex. |
Volume: |
191 |
Issue: |
11 |
Pages: |
1869-79 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
523
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
548
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
548
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
462
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
553
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
523
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Gerhard DS |
Year: |
2004 |
Journal: |
Genome Res |
Title: |
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
Volume: |
14 |
Issue: |
10B |
Pages: |
2121-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huttlin EL |
Year: |
2010 |
Journal: |
Cell |
Title: |
A tissue-specific atlas of mouse protein phosphorylation and expression. |
Volume: |
143 |
Issue: |
7 |
Pages: |
1174-89 |
|
•
•
•
•
•
|